Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
D008237:Lysergic Acid; D008238:Lysergic Acid Diethylamide / Q000031:analogs & derivatives; D008784:Methysergide; D008881:Migraine Disorders / Q000628:therapy*; D014653:Vascular Headaches
D008238:Lysergic Acid Diethylamide; D008237:Lysergic Acid; D008784:Methysergide
LYSERGIC ACID DIETHYLAMIDE/related compounds; MIGRAINE/therapy